Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti-PD-1 treatment with nivolumab.
about
Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas.PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.Effect of Gamma Knife Radiosurgery and Programmed Cell Death 1 Receptor Antagonists on Metastatic Melanoma.Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
P2860
Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti-PD-1 treatment with nivolumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Long-term control and partial ...... PD-1 treatment with nivolumab.
@en
Long-term control and partial ...... PD-1 treatment with nivolumab.
@nl
type
label
Long-term control and partial ...... PD-1 treatment with nivolumab.
@en
Long-term control and partial ...... PD-1 treatment with nivolumab.
@nl
prefLabel
Long-term control and partial ...... PD-1 treatment with nivolumab.
@en
Long-term control and partial ...... PD-1 treatment with nivolumab.
@nl
P2860
P356
P1433
P1476
Long-term control and partial ...... PD-1 treatment with nivolumab.
@en
P2093
Antonios Valavanis
Patrick Roth
P2860
P304
P356
10.1093/NEUONC/NOW265
P577
2017-03-01T00:00:00Z